6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Sensory Processing Deficits in Addicts
Sensory processing deficits are common among individuals with addiction, affecting their ability to interpret and respond to sensory stimuli. These deficits can manifest as heightened sensitivity or diminished response to environmental cues, potentially exacerbating the addictive cycle. Substances like alcohol, opioids, and stimulants may alter brain circuits responsible for sensory integration, impairing decision-making and emotional regulation. Treatment strategies often include sensory-based therapies such as mindfulness, art therapy, or sensory integration exercises. Addressing sensory processing issues in addiction recovery can enhance coping mechanisms, reduce cravings, and improve overall quality of life. A multidisciplinary approach, combining psychological support and sensory rehabilitation, is crucial for sustainable recovery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States